+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Comprehensive analysis of published studies involving systemic treatment for chondrosarcoma of bone between 2000 and 2013



Comprehensive analysis of published studies involving systemic treatment for chondrosarcoma of bone between 2000 and 2013



Clinical Sarcoma Research 4: 11



The majority of patients with chondrosarcoma of bone have an excellent overall survival after local therapy. However, in case of unresectable locally advanced or metastatic disease the outcome is poor and limited treatment options exist. Therefore we conducted a survey of clinical phase I or II trials and retrospective studies that described systemic therapy for chondrosarcoma patients. Using PubMed, clinicaltrials.gov, the Cochrane controlled trial register and American Society of Clinical Oncology (ASCO) abstracts a literature survey was conducted. From the identified items, data were collected by a systematic analysis. We limited our search to semi-recent studies published between 2000 and 2013 to include modern drugs, imaging techniques and disease evaluations. A total of 31 studies were found which met the criteria: 9 phase I trials, 11 phase II and 8 retrospective studies. In these studies 855 chondrosarcoma patients were reported. The tested drugs were mostly non-cytotoxic, either alone or in combination with another non-cytotoxic agent or chemotherapy. Currently two phase I trials, one phase IB/II trial and three phase II trials are enrolling chondrosarcoma patients. Because chondrosarcoma of bone is an orphan disease it is difficult to conduct clinical trials. The meagre outcome data for locally advanced or metastatic patients indicate that new treatment options are needed. For the phase I trials it is difficult to draw conclusions because of the low numbers of chondrosarcoma patients enrolled, and at different dose levels. Some phase II trials show promising results which support further research. Retrospective studies are encouraged as they could add to the limited data available. Efforts to increase the number of studies for this orphan disease are urgently needed.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 052269863

Download citation: RISBibTeXText

PMID: 25126409

DOI: 10.1186/2045-3329-4-11


Related references

Yoga as a Therapeutic Intervention: A Bibliometric Analysis of Published Research Studies from 1967 to 2013. Journal of Alternative and Complementary Medicine 21(10): 586-592, 2015

Outcome and Trends in Treatment of Systemic Juvenile Idiopathic Arthritis in the German National Pediatric Rheumatologic Database, 2000-2013. Arthritis and Rheumatology 68(12): 3023-3034, 2016

What's new in atopic eczema? An analysis of systematic reviews published in 2012 and 2013. Part 2. Treatment and prevention. Clinical and Experimental Dermatology 40(4): 349-54; Quiz 354-5, 2016

Effects on bone mass of long term treatment with thyroid hormones A meta-analysis of all published cross-sectional studies. Therapie (Paris) 0(Suppl. ): 436, 1995

Ki-67 as a prognostic marker in early-stage non-small cell lung cancer in Asian patients: a meta-analysis of published studies involving 32 studies. Bmc Cancer 15: 520, 2015

Current status of water environment and their microbial biosensor techniques - Part II: Recent trends in microbial biosensor development. Analytical and Bioanalytical Chemistry 410(17): 3967-3989, 2018

Comprehensive treatment of advanced neuroblastoma involving autologous bone marrow transplant. Acta Paediatrica Japonica 37(4): 493-499, 1995

Ki-67 as prognostic marker in early breast cancer: a meta-analysis of published studies involving 12 155 patients. British Journal of Cancer 96(10): 1504-1513, 2007

Drug-poisoning deaths involving heroin: United States, 2000-2013. Nchs Data Brief 2016(190): 1-8, 2016

Second-line treatment in advanced pancreatic cancer: a comprehensive analysis of published clinical trials. Annals of Oncology 24(8): 1972-1979, 2013

Disodium cromoglycate in the treatment of systemic mastocytosis involving only bone. Acta Haematologica 74(2): 108-110, 1985

Diagnosis and treatment of posterior sacroiliac complex pain: a systematic review with comprehensive analysis of the published data. Pain Medicine 16(2): 257-265, 2015

Flow cytometric immunophenotypic analysis of systemic mastocytosis involving bone marrow. Archives of Pathology and Laboratory Medicine 138(9): 1210-1214, 2014

Effects of postmenopausal hormone replacement therapy on lipid, lipoprotein, and apolipoprotein (a) concentrations: Analysis of studies published from 1974-2000. Fertility and Sterility 75(5): 898-915, 2001